Literature DB >> 16669875

Serum-dependence of AMPA receptor-mediated proliferation in glioma cells.

Yukari Yoshida1, Keisuke Tsuzuki, Shogo Ishiuchi, Seiji Ozawa.   

Abstract

Glutamate may cause Ca(2+) entry through Ca(2+)-permeable glutamate receptors, which in turn stimulates the anti-apoptotic signaling cascade in glioma cells. It was found that a human glioma cell line, U-87 MG, expressed subunits of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate acid-type glutamate receptors (AMPAR). Ca(2+) entry through AMPAR was detected in approximately 40% of U-87 MG cells. AMPAR agonists facilitated cell proliferation in low-serum medium containing 0.5% fetal calf serum (FCS). Unexpectedly, cell proliferation by the activation of AMPAR was not detected in serum-rich medium containing 10% FCS. Overexpression of Ca(2+)-permeable AMPAR facilitated proliferation of U-87 MG cells in the low-serum condition, whereas it had again no effect in the serum-rich condition. Cell proliferation of U-87 MG cells is likely to be under the regulation of both growth factors contained in the serum and Ca(2+) entry through AMPAR, and that the latter regulation becomes evident only when serum factors are deprived of culture medium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16669875     DOI: 10.1111/j.1440-1827.2006.01954.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  11 in total

1.  Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line.

Authors:  Daniel Pretto Schunemann; Ivana Grivicich; Andréa Regner; Lisiane Freitas Leal; Daniela Romani de Araújo; Geraldo Pereira Jotz; Carlos Alexandre Fedrigo; Daniel Simon; Adriana Brondani da Rocha
Journal:  Pathol Oncol Res       Date:  2009-12-08       Impact factor: 3.201

Review 2.  Glutamate transporters in the biology of malignant gliomas.

Authors:  Stephanie M Robert; Harald Sontheimer
Journal:  Cell Mol Life Sci       Date:  2013-11-27       Impact factor: 9.261

3.  AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.

Authors:  Yuji Piao; Li Lu; John de Groot
Journal:  Neuro Oncol       Date:  2008-10-28       Impact factor: 12.300

4.  Biochemical constitution of extracellular medium is critical for control of human breast cancer MDA-MB-231 cell motility.

Authors:  Huiyan Pan; Mustafa B A Djamgoz
Journal:  J Membr Biol       Date:  2008-06-25       Impact factor: 1.843

5.  Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.

Authors:  Stuart A Grossman; Xiaobu Ye; Marc Chamberlain; Tom Mikkelsen; Tracy Batchelor; Serena Desideri; Steven Piantadosi; Joy Fisher; Howard A Fine
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

6.  Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.

Authors:  C Ciceroni; M Bonelli; E Mastrantoni; C Niccolini; M Laurenza; L M Larocca; R Pallini; A Traficante; P Spinsanti; L Ricci-Vitiani; A Arcella; R De Maria; F Nicoletti; G Battaglia; D Melchiorri
Journal:  Cell Death Differ       Date:  2012-11-23       Impact factor: 15.828

Review 7.  Glutamate and its receptors in cancer.

Authors:  Andrzej Stepulak; Radoslaw Rola; Krzysztof Polberg; Chrysanthy Ikonomidou
Journal:  J Neural Transm (Vienna)       Date:  2014-03-09       Impact factor: 3.575

8.  Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.

Authors:  Michael C Oh; Joseph M Kim; Michael Safaee; Gurvinder Kaur; Matthew Z Sun; Rajwant Kaur; Anna Celli; Theodora M Mauro; Andrew T Parsa
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

9.  Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.

Authors:  Zarina Yelskaya; Vangie Carrillo; Ewa Dubisz; Hira Gulzar; Devon Morgan; Shahana S Mahajan
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

10.  Neurodegeneration and the Brain Tumor Microenvironment. [corrected].

Authors:  Nicolai E Savaskan; Zheng Fan; Thomas Broggini; Michael Buchfelder; Ilker Y Eyüpoglu
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.